The first experience of the use the Russian β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis

Autor:	Popova, E. V., Alexei Boyko, Davydovskaya, M. V., Demina, T. L., Kukel, T. M., Lashch, N. Y., Popova, N. F., Khachanova, N. V., Shchur, S. G., Gusev, E. I.
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::505e142575120fe5b73221abcc00ab9e http://www.scopus.com/inward/record.url?eid=2-s2.0-84892875936&partnerID=MN8TOARS Zobrazit plný text záznamu